Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. USO
2. SPY
3. AMZN
4. GNK
5. FLUT
6. TMUS
7. AVGO
8. KRUS
9. MTZ
10. BKR

Go back to Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
(NASDAQ: NERV) Delayed: 4.62 -0.15 (3.14%)
Previous Close $4.77    52 Week High $15.84 
Open $4.69    52 Week Low $3.45 
Day High $4.73    P/E N/A 
Day Low $4.56    EPS $0.00 
Volume 166,227